Tehran University of Medical Sciences

Science Communicator Platform

Stay connected! Follow us on X network (Twitter):
Share this content! By
Comparison of Leptin and Ferritin Levels in Beta-Thal-Assemia Major and Healthy Individuals Publisher



Smk Nourbakhsh Seyed MK ; E Hashemi E ; M Kheyri MARYAM ; M Bahadoram MOHAMMAD ; Bk Dehdezi Bijan KEIKHAEI ; S Hassanzadeh SHAKIBA
Authors

Source: New Armenian Medical Journal Published:2024


Abstract

Introduction: Beta-thalassemia major is an inherited hematologic disorder that is characterized by decreased or lack in the synthesis of beta-hemoglobin sequence. An increase in ferritin leads to a decrease in leptin in healthy individuals. This study aimed to compare leptin and ferritin levels in the patients with beta-thalassemia major and healthy individuals. Material and Methods: This cross-sectional study was conducted in 2018-2019. The study participants were divided into two groups including 57 patients with beta-thalassemia major in the case group and 57 healthy volunteers in the control group. Leptin and ferritin levels were measured using the ELISA kit. The data were entered into SPSS 21 software and were compared and analyzed using the T-test. Results: The mean leptin level in the healthy individuals and patients with beta-thalassemia major was 10.17 ± 8.29 ng/ml and 3.23 ± 3.22 ng/ml, respectively. The ferritin level in healthy individuals was 99.14 ± 90.5 ng/ml compared to 1233.456 ± 0.701 ng/ml in the patients with beta-thalassemia major. Conclusion: In beta-thalassemia major patients, the leptin level was lower compared to healthy individuals. In addition, an increase in ferritin levels leads to a decrease in leptin levels in healthy individuals. However, this finding was not observed in patients with beta-thalassemia major. © 2025 Elsevier B.V., All rights reserved.
Related Docs
View other Related Docs
1. Relationship Between Serum Ferritin and Hemoglobin Levels Determined by Cardiac and Hepatic T2 Mri in Beta-Thalassemia Intermedia and Major Patients, Frontiers in Biology (2017)
2. Major Histocompatibility Complex (Mhc) Antigens Polymorphism and Alloimmunization Study in Thalassemia Patients With Febrile Non-Hemolytic Transfusion Reaction (Fnhtr), Transfusion Clinique et Biologique (2023)
3. The Effect of Quercetin on Iron Overload and Inflammation in Β-Thalassemia Major Patients: A Double-Blind Randomized Clinical Trial, Complementary Therapies in Medicine (2019)
Experts (# of related papers)
View all Related Experts
Amir Ali Hamidieh (2)
Mohammad Reza Mohajeri Tehrani (1)
Other Related Docs
4. Evaluation of Serum Transferrin Receptors in Children With Iron Deficiency Anemia, Acta Medica Mediterranea (2016)
5. Renal Hemosiderosis Among Iranian Transfusion Dependent Β-Thalassemia Major Patients, International Journal of Hematology-Oncology and Stem Cell Research (2017)
6. The Association of Pro-Oxidant/Antioxidant Balance and Blood Parameters in Patients With Beta-Thalassemia Major: A Cross-Sectional Study, Blood Research (2023)
7. Investigation of Frequency of Hypogonadism in Thalassemia Major Patients of Hazrat-E Rasool Akram Hospital During 2013-2017, International Medical Journal (2020)
8. Correlation Between Heart and Liver Iron Levels Measured by Mri T2* and Serum Ferritin in Patients With Β-Thalassemia Major, International Journal of Pediatrics (2016)
9. Mir-30A Regulates Γ-Globin Expression in Erythoid Precursors of Intermedia Thalassemia Through Targeting Bcl11a, Molecular Biology Reports (2020)
10. Cytokine Levels in Patients With Β-Thalassemia Major and Healthy Individuals: A Systematic Review and Meta-Analysis, Clinical Laboratory (2022)
11. Comparison of Blood Transfusion Plus Chelation Therapy and Bone Marrow Transplantation in Patients With Β-Thalassemia: Application of Sf-36, Eq-5D, and Visual Analogue Scale Measures, International Journal of Health Policy and Management (2015)
12. Hbb Mutations and Hba2 Level: Escaping the Carrier Screening Programs, Clinical Case Reports (2021)
13. Two Trade Names of Deferasirox (Osveral® and Exjade®) in Reduction of Iron Overload Parameters in Major Betathalassemia Patients: A Randomized Open Labeled Clinical Trial, Caspian Journal of Internal Medicine (2022)
14. Guideline Guideline for the Diagnosis and Treatment of Diabetes Mellitus in Patients With Transfusion-Dependent Thalassemia, Iranian Journal of Blood and Cancer (2023)
15. Health-Related Quality of Life and Health Utility Values in Beta Thalassemia Major Patients Receiving Different Types of Iron Chelators in Iran, International Journal of Hematology-Oncology and Stem Cell Research (2016)
16. Serum Ferritin Levels and Irregular Use of Iron Chelators Predict Liver Iron Load in Patients With Major Beta Thalassemia: A Cross-Sectional Study, Croatian Medical Journal (2019)
17. Prevalence of Alloantibodies in Thalassemia Patients and Its Relationship With Age, Gender and Blood Group, Acta Medica Iranica (2023)
18. First Report of a Dominantly Inherited Β-Thalassemia Caused by a Novel Elongated Β-Globin Chain, Hemoglobin (2016)
19. Screening for Thalassemia Carriers in Populations With a High Rate of Iron Deficiency: Revisiting the Applicability of the Mentzer Index and the Effect of Iron Deficiency on Hb A2 Levels, Hemoglobin (2015)
20. How Age, Sex and Transfusion Affects the Incidence of Endocrine and Bone Density Disorders in Major Thalassemic Patients, Iranian Journal of Public Health (2024)